-
Report | 2020.04.03
Coronavirus SARS-CoV-2: A look back at three months of mobilisation against an emerging disease (COVID-19)
On December 31, 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. It was the official beginning of an epidemic that would rapidly become worldwide. In January, a task force was put in place at the Institut Pasteur and research projects were quickly launched. Here is a look back at three...
-
News | 2020.04.15
MOOC Advances in Stem Cell Biology
2ND EDITION OF THE FREE ONLINE COURSE OF THE INSTITUT PASTEURRealized with the support of the Fondation Ipsen, under the aegis of Fondation de FranceStem cells have the spectacular ability to restore the function of damaged tissues, providing major opportunities for fundamental studies on organogenesis, regeneration, diseases, and ageing. In spite of intense research in this field, many...
-
News | 2020.03.18
Pasteur's Nephew – Or the Adventurous Life of Adrien Loir, Scholar and Globe-Trotter
What would you say if, during this period of confinement, you had the opportunity to meet up (virtually) with Louis Pasteur and his nephew Adrien Loir? Why not make the most of this unique time to catch up on some reading and find out more about Louis Pasteur and his family? There are plenty of bookshops available online! Pasteur's Nephew – Or the Adventurous Life of Adrien Loir, Scholar and...
-
News | 2020.04.16
MOOC Vaccinology
NEW EDITION OF THE FREE ON-LINE COURSE OF INSTITUT PASTEUR Realized with the support of the Fondation Ipsen, under the aegis of Fondation de France.Vaccines are among the most effective public health interventions currently available. Several diseases have been eradicated or reduced drastically through vaccination. Together, with antibiotics and clean water, vaccines have increased life...
-
Document de presse | 2020.04.16
Bill & Melinda Gates Medical Research Institute and the Institut Pasteur to Develop a Novel Vaccine Against Shigella
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an exclusive collaboration and license agreement to jointly develop a quadrivalent synthetic carbohydrate-based conjugate vaccine against Shigella flexneri serotypes 2a, 3a, and 6 and Shigella sonnei. Gates MRI will have an exclusive license for manufacture and commercialization of...
-
News | 2020.04.15
COVID-19 - The Bioinformatics and Biostatistics Hub on the front line
Like many other research teams at the Institut Pasteur, the Bioinformatics and Biostatistics Hub is engaged in fighting against the COVID-19 pandemic by participating in the curation of GISAID data (Global Initiative on Sharing All Influenza Data). The Hub is the service division of the Computational Biology Department, and is composed of 50 experts in biostatistics and bioinformatics.At the end...
-
Article | 2020.04.17
Pasteur Network Talent Awards
A stimulating environment, support through training, and dedicated monitoring are the keys to scientific excellence. The Institut Pasteur has set itself the priority of supporting career development for researchers with high potential within the Pasteur Network.
-
News | 2020.04.24
HIV-1: revealed during the nuclear entry step. Direct visualization in living cells using “HIV-1 ANCHOR” technology
Researchers from Institut Pasteur (Paris), Paris-Descartes University and CNRS, studying HIV-1, have been able to visualize in living cells (direct visualization) the retrotranscribed viral genome, which is capable to integrate into the human genome. They also observed that multiple viral capsid proteins are responsible to lead the retrotranscribed HIV-1 DNA inside the host nucleus. Those direct...
-
News | 2020.04.22
Neurodevelopmental disorders: a daily practical guide by InovAND to help families deal with the difficulties of lockdown
Institut Pasteur partner InovAND, the Excellence Center in the Greater Paris region specializing in autism spectrum and neurodevelopmental disorders, is publishing a practical guide every day to help families overcome the difficulties associated with the lockdown.The lockdown soon proved to be a testing time for many families, especially those with a child affected by neurodevelopmental disorders...
-
News | 2020.04.14
COVID-19, chronicle of an expected pandemic / Exiting lockdown or the sum total of all dangers
Professor Philippe Sansonetti explains that a lockdown was needed because social distancing measures were not enough on their own. He goes on to outline the conditions that will be required for a future exit strategy – but makes it clear that this strategy will not signal the end of distancing measures. This article was written by Philippe Sansonetti and published on the website "La Vie des...
